Research identifies antigen-specific peripheral T follicular helper cells in COVID-19 infected patients
Researchers have found peripheral T follicular helper cell responses to different structural proteins of SARS-CoV-2 and have studied how the response occurs over time.
Several studies of the SARS-CoV-2 virus infection, causing COVID-19, have reported how the human immune system responds to the infection. Many reports have found T-cell responses to the infection in almost all of the recovered patients.
Many of the current vaccine trials are using the presence of neutralizing antibodies as a measure of how efficient the vaccine is. Studies have found a correlation between neutralizing antibodies and protection from infection in non-human primates. Thus, understanding how T cells contribute to the formation of these antibodies is important.
However, it is challenging to direct study lymph tissues in humans, so peripheral T follicular cells (pTfh), or T follicular helper cells (Tfh) found in the blood, can help understand T cell responses.
There are only a few studies of pTfh for SARS-CoV-2. One study reported that the frequencies of pTfh increased in cases with severe infection. Upon testing deceased COVID-19 patients, another study found that Tfh response may be diminished in acute infections.
Although another study has shown a relation between SARS-CoV-2 spike protein-specific Tfh response and neutralizing antibodies, there are still many questions, such as if these responses contribute to the formation of antibodies and when after the infection these responses occur.
No hay comentarios:
Publicar un comentario